Sandbox:Qurrat
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Qurrat-ul-ain Abid, M.D.[2]
- On gross pathology, characteristic findings of T-cell prolymphocytic leukemia, include:[1]
- No remarkable findings
- On microscopic histopathological analysis, characteristic findings of T-cell prolymphocytic leukemia, include:[1]
- The immunophenotype CD4+/CD8- (present in 60% of cases)
- The immunophenotype CD4+/CD8+ (present in 25%)
Morphological Variant | Microscopic Findings |
---|---|
Typical T-cell
prolymphocytic leukemia |
|
Small cell variant |
|
Cerebriform
(Sézary cell-like) variant |
tab
Differential diagnosis of neck masses
Differential diagnosis of neck masses include:
Category | Diseases | Benign or Malignant | Clinical manifestation | Paraclinical findings | Gold standard diagnosis | Associated findings | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Demography | History | Symptoms | Signs | Lab findings | Histopathology | Imaging | ||||||||||
Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | |||||||||||
Congenital | Branchial cleft cyst[4] |
|
|
|
- | +/- |
|
|
- | - | - |
|
|
| ||
Thyroglossal duct cyst[5][6] |
|
|
|
- | - |
|
- | - | - | - |
|
|
- | |||
Haemangioma[7] |
|
|
|
- | - |
|
|
- | - |
|
|
|
| |||
Vascular malformations | ||||||||||||||||
Lymphatic malformations | ||||||||||||||||
Laryngocele[8][9][10] |
|
|
|
- | +/- |
|
- | - |
|
- |
|
|
|
- | ||
Ranula[11] |
|
|
|
- | - |
|
- | |||||||||
Teratoma | Incidence: 1:4000 births | High ALP levels | ||||||||||||||
Dermoid cyst[12][13] |
|
|
|
- | - |
|
|
- | - |
|
|
|||||
Thymic cyst[14] |
|
|
|
- | - |
|
- | - |
|
|
||||||
Category | Diseases | Benign or Malignant | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Inflammatory | Acute sialadenitis [15] |
|
|
|
+ | - |
|
|
+ |
|
|
|
||||
Chronic sialadenitis |
|
|
|
+ | - |
|
|
|
||||||||
Reactive viral lymphadenopathy | CMV[16] |
|
|
- | - |
|
|
|
|
|||||||
EBV[17][18] |
|
|
- | - |
|
|
|
|
|
|||||||
HIV |
|
|||||||||||||||
Viral URI | ||||||||||||||||
Bacterial lymphadenopathy | Tularemia | |||||||||||||||
Brucellosis | ||||||||||||||||
Cat-scratch disease | ||||||||||||||||
Actinomycosis | ||||||||||||||||
Mycobacterial infections | ||||||||||||||||
Staphylococcal or streptococcal infection | ||||||||||||||||
Parasitic lymphadenopathy | Toxoplasma gondii | |||||||||||||||
Sarcoidosis | ||||||||||||||||
Amyloidosis | ||||||||||||||||
Sjögren syndrome | ||||||||||||||||
Castleman disease (angiofollicular lymphoproliferative disease) | ||||||||||||||||
Kikuchi disease (histiocytic necrotizing lymphadenitis) | ||||||||||||||||
Kimura disease | ||||||||||||||||
Rosai-Dorfman disease | ||||||||||||||||
Kawasaki disease | ||||||||||||||||
Category | Diseases | Benign or Malignant | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings | |
Neoplasm | Primary thyroid tumor | |||||||||||||||
Salivary gland neoplasm | Pleomorphic adenoma | + | ||||||||||||||
Warthin's tumor | + | |||||||||||||||
Lymphoepithelioma | + | |||||||||||||||
Oncocytoma | Benign |
|
|
+/- | +/- | Firm, multilobulated and mobile mass |
|
- |
|
Epithelial cells with eosinophilic granular cytoplasm rich in mitochondria |
|
Incisional biopsy and histopathological examination | ||||
Monomorphic adenoma [20][21][22] | Benign or malignant |
|
|
+/- | +/- | Nodular and fluctuant swelling |
|
+/- | Normal |
|
Ultrasound:
|
Incisional biopsy and histopathological examination | ||||
Mucoepidermoid carcinoma | Malignant |
|
|
+/- | +/- | Cystic and solid mass | Normal | +/- | Association with CMV | Gross findings:
Microscopic findings: |
cystic and solid component with variable appearance | Incisional biopsy and histopathological examination | ||||
Adenoid cystic carcinoma [24] | Malignant | Age: 40s to 60s
Gender: Female predominance |
Slow growing painless mass | +/- | +/- | Solid mass | Normal to ulcerated lesions | +/- | Slow growing rare tumor with low recurrence | Gross findings: Tubular, cribriform and solid pattern of growth
Microscopic findings: Components of large cells with pleomorphic nuclei increased mitotic activity, and focal necrosis. |
Imaging reveal dimensions of the tumor, local spread and distant metastasis | Biopsy and histopathological examination | ||||
Adenocarcinoma | Malignant | Age: young age predilection | Its a tumor of minor salivary glands so may present as small ulceration or nodules in oral cavity | - | - | Small nodules and oral cavity with or without lymphadenopathy | Skin stays intact or may show some ulceration | +/- | There are several subtypes of adenocarcinoma.
Some are more infiltrating in nature |
Can be normal or may show anemia and blood cell disorders with distant bone invasion | On histology it is confused with Adeocyctic carcinoma with components of gland and cyst formations.
It has more perineural invasion. |
CT and MRI both can be used to visualize the tumor. MRI being more accurate for adjacent tissue involvement and lymphadenopathy. | Biopsy and histopathological examination | |||
Salivary duct cancer | Malignant
(Highly aggressive) |
Incidence: 1% to 3%
Gender: Men Mean age: 55 to 61 years |
Presents as rapidly growing mass | +/- | +/- |
|
Jaw involvement results in ulceration of mucosa and may cause ulceration of skin as well | +/- | Rapidly growing mass with jaw involvement and facial paralysis in case of facial nerve involvement | Pathomorphologically tumor of salivary ducts resembles tumor of breast ducts, and that where it name is derived from | Gross findings:
|
Non-specific features on CT and MRI but it can show neural and jaw involvement. | Biopsy and histopathological examination | |||
Squamous cell carcinoma | Malignant | Incidence: rare tumor
Age: Old age , 61 to 68 years Gender: Male predilection |
Present as painful growing mass on jaw | + | - |
|
Thinning and discoloration of skin | - | Submandibular gland predilection | Past radiation exposure is a strong risk factor | Gross findings: Shows skin tissue and thinning of skin
Microscopically findings: Nest and solid sheets of tumor cells arranged in glandular pattern. It is derived from epidermoid cells of salivary gland. May show vascular invasion and inflammatory infiltrate. Immunohistochemical staining can be used to mark the squamous and keratin component. |
Tumor dimension can be delineated using both CT and MRI | Biopsy and histopathological examination | |||
Parathyroid cancer | Malignant | Incidence: Rare
Mean age : 44 to 54 years Gender: Female predilection |
|
+ | + | Lower neck mass with | Skin stays intact most of the time | - | Labs may show hypercalcemia and its consequences such as pancreatitis and decrease bone density on DEXA scan. |
|
Microscopic findings:Tumor shows trabecular growth pattern with high mitosis and surrounding thick fibrous bands. Capsular involvement and vascular invasion is common |
|
Biopsy and histopathological examination | |||
Carotid body tumors | Benign | Age: 26-55 years
Gender: Male predominance |
|
- | - |
|
Normal | - | Urine analysis for metanephrine levels | May show Increased catecholamine levels | Microscopically they are extra- adrenal paragangliomas |
|
Histopathology analysis and catecholamine levels | |||
Paraganglioma | Benign (Majority)
Malignant (rare) |
Mean age:age from 50 to 70 years
Gender: More in females |
May be an accidental finding depending on their secretory nature or present with following symptoms:
Catecholaminesecreting paragangliomas present with : |
- | - | No visible mass as they are located deep in the the neck along the glossopharyngeal and vagal nerves. | skin stays intact and usually is normal | - | Associated with some hereditary syndromes and MEN2B syndrome, Neurofibromatosis type 1 and VHL disease | Biochemical testing may show catecholamine metabolites in serum or urine samples | These are highly vascular tumors that involves nerves around vessels
Gross findings:
Round or polygonal cells arranged inside capsule in the form of nests or forming trabecular structures. Differentiation between benign or malignancy form is done depending microscopic features of invasion and high mitotic index |
Following imaging techniques can be used to diagnose the tumor:
As these are secretory tumors further testing with following techniques can confirm diagnoses:
|
Imaging and serum catecholamine analysis | |||
Schwannoma | Benign | Rare tumor
Incidence: 1% to 10% |
Slow growing mass presents with the localized neural deficit depending on the site of peripheral nerve involved.
Vagal involvement: Sympathetic nerve involvement may present as Horner's syndrome:
Vestibular Schwannoma (most common): |
+ | +/- | Multiple slow growing nodules on the skin | Normal | - | Associated with neurofibromatosis type II.
Most common nerve involved in vestibular nerve |
May be normal |
vagus nerve or superior cervical sympathetic chain being most common locations.
|
Imaging can diagnose the tumor. Its hard to discriminate Carotid body tumor from Schwannoma on CT. MRI and MRI angiography can confirm the diagnoses. | Imaging is used for diagnoses | |||
Lymphoma [44][45] | Benign/ malignant | Age: Predilection for older age
Mean age: 55 |
|
- | +/- |
|
Rash and pruritus | - |
With acquired form of C1 inhibitor deficiency patients may develop angioedema |
|
|
|
Lymph node biopsy coupled with cytometry | |||
Liposarcoma [50][51] | Malignant | Rare tumors
Age: Relatively in older age Gender: No gender predilection |
Mobile masses with very few symptoms until they grow enough to compress the surrounding structures, which produces symptoms of neural deficit, pain, tingling or skin changes. | +/- | - | Mobile soft mass with intact overlying skin and in some cases with blue discoloration due to intra-lesion hemorrhage | Intact and normal color | - | - | Normal | Gross findings:
Bulk of yellow colored fat tissue. Adipose tissue containing that containing lipoblasts atypical nucleus pushed to side by intracytoplasmic vacuoles. Tissue biopsy may show histological sub-groups:
|
Imaging is not usually used for diagnoses except to look for deeper invasion.
Ultrasound shows homogeneous hyperechoic mass. |
Biopsy and histopathology analysis | |||
Lipoma [54][55][56] | Benign |
|
One or multiple soft, painless skin nodules.
May causes pain or compressive symptoms |
+/- | - | Mobile soft nodule with intact overlying skin | Intact and normal in color | - | Multiple lipomas are associated with familial multiple lipomatosis | Normal | Diagnoses is usually clinical but tissue biopsy may show
Bundle of well-demarcated lipocytes with single nuclei aligned to the side and intra-cytoplasimic fat granules. |
Diagnoses is usually clinical but ultrasound is used to differentiate lipoma from other benign lesions such as epidermoid cyst or a ganglion. |
Clinical evaluation
and tissue biopsy |
|||
Glomus vagale, glomus jugulare tumors | Benign |
Rare tumor |
|
- | +/- |
|
Normal and mobile overlying skin | - | Secretory tumors are diagnosed by biochemical testing using Metaiodobenzylguanidine (MIBG) , followed by imaging to locate the tumor | Normal |
|
|
Imaging and MIBG testing | |||
Metastatic head and neck cancer | Malignant | Depends on the nature of metastatic tumor |
|
- | +/- | Non-tender mass in the neck or non-tender lymphadenopathy | Normal skin | - | Majority of metastatic head and neck cancer metastatise from GIT and lungs and are squamous cell caners | Vary depending on the underlying cancer | Histology of primary cancer | CT and MRI shows extend of the tumor and other regions of metastasis | Biopsy and histopathology of the primary site of tumor | |||
Other | Laryngeal cancer | Benign/Malignant |
|
|
+/- | +/- |
|
- | - |
human papillomavirus (HPV) infection |
HPV testing may show HPV infection | FNA of neck mass followed by biopsy is done to diagnose laryngeal cancer. It show type cancerous cells. |
|
Laryngoscopy and biopsy | ||
Arteriovenous fistula | Benign/Malignant | Depends on the risk factors |
|
- | - |
|
Intact overlying skin with normal color and texture | - | May be associated with vasculopathies and metastatic invasion of vessels and neck surgery | Varies depending on the etiology | MR angiography may be used to visualize the tract | MR angiography | ||||
Thyroid nodule/ Goiter | Benign/ Malignant |
|
|
+/- | +/- |
|
Intact | - | Goiter is most commonly associated with iodine deficiency |
|
FNA is done in case of goiter and core biopsy is performed if malignancy is suspected | USG: Shows nodular or non- nodular lesions in Thyroid. US is better than CT.
Thyroid radionuclide imaging: Shows radioiodine uptake and is usually cold in case of malignancy and may be cold or hot in case of goiter. |
Biopsy and histopathology of nodules | |||
Category | Diseases | Benign | Demography | History | Pain | Dysphagia | Mass exam | Skin changes | LAP | Others | Lab findings | Histopathology | Imaging | Gold standard diagnosis | Associated findings |
References
- ↑ 1.0 1.1 Graham RL, Cooper B, Krause JR (2013). "T-cell prolymphocytic leukemia". Proc (Bayl Univ Med Cent). 26 (1): 19–21. PMC 3523759. PMID 23382603.
- ↑ Matutes E, Brito-Babapulle V, Swansbury J, Ellis J, Morilla R, Dearden C, Sempere A, Catovsky D (December 1991). "Clinical and laboratory features of 78 cases of T-prolymphocytic leukemia". Blood. 78 (12): 3269–74. PMID 1742486.
- ↑ Ravandi F, O'Brien S (December 2005). "Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatment". Mayo Clin. Proc. 80 (12): 1660–74. doi:10.4065/80.12.1660. PMID 16342661.
- ↑ Nahata, Vaishali (2016). "Branchial cleft cyst". Indian Journal of Dermatology. 61 (6): 701. doi:10.4103/0019-5154.193718. ISSN 0019-5154.
- ↑ Amos J, Shermetaro C. PMID 30085599. Missing or empty
|title=
(help) - ↑ Deaver MJ, Silman EF, Lotfipour S (August 2009). "Infected thyroglossal duct cyst". West J Emerg Med. 10 (3): 205. PMC 2729228. PMID 19718389.
- ↑ Léauté-Labrèze, C.; Prey, S.; Ezzedine, K. (2011). "Infantile haemangioma: Part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities". Journal of the European Academy of Dermatology and Venereology. 25 (11): 1245–1253. doi:10.1111/j.1468-3083.2011.04102.x. ISSN 0926-9959.
- ↑ Werner RL, Schroeder JW, Castle JT (March 2014). "Bilateral laryngoceles". Head Neck Pathol. 8 (1): 110–3. doi:10.1007/s12105-013-0478-4. PMC 3950389. PMID 23881550.
- ↑ Prasad KC, Vijayalakshmi S, Prasad SC (December 2008). "Laryngoceles - presentations and management". Indian J Otolaryngol Head Neck Surg. 60 (4): 303–8. doi:10.1007/s12070-008-0108-8. PMC 3476818. PMID 23120570.
- ↑ Mahdoufi R, Barhmi I, Tazi N, Abada R, Roubal M, Mahtar M (July 2017). "Mixed Pyolaryngocele: A Rare Case of Deep Neck Infection". Iran J Otorhinolaryngol. 29 (93): 225–228. PMC 5554815. PMID 28819622.
- ↑ Packiri S, Gurunathan D, Selvarasu K (September 2017). "Management of Paediatric Oral Ranula: A Systematic Review". J Clin Diagn Res. 11 (9): ZE06–ZE09. doi:10.7860/JCDR/2017/28498.10622. PMC 5713871. PMID 29207849.
- ↑ Paradis, Josée; Koltai, Peter J. (2015). "Pediatric Teratoma and Dermoid Cysts". Otolaryngologic Clinics of North America. 48 (1): 121–136. doi:10.1016/j.otc.2014.09.009. ISSN 0030-6665.
- ↑ Gaddikeri S, Vattoth S, Gaddikeri RS, Stuart R, Harrison K, Young D, Bhargava P (2014). "Congenital cystic neck masses: embryology and imaging appearances, with clinicopathological correlation". Curr Probl Diagn Radiol. 43 (2): 55–67. doi:10.1067/j.cpradiol.2013.12.001. PMID 24629659.
- ↑ Gaddikeri, Santhosh; Vattoth, Surjith; Gaddikeri, Ramya S.; Stuart, Royal; Harrison, Keith; Young, Daniel; Bhargava, Puneet (2014). "Congenital Cystic Neck Masses: Embryology and Imaging Appearances, With Clinicopathological Correlation". Current Problems in Diagnostic Radiology. 43 (2): 55–67. doi:10.1067/j.cpradiol.2013.12.001. ISSN 0363-0188.
- ↑ Abdel Razek A, Mukherji S (June 2017). "Imaging of sialadenitis". Neuroradiol J. 30 (3): 205–215. doi:10.1177/1971400916682752. PMC 5480791. PMID 28059621. Vancouver style error: initials (help)
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Mohseni S, Shojaiefard A, Khorgami Z, Alinejad S, Ghorbani A, Ghafouri A (March 2014). "Peripheral lymphadenopathy: approach and diagnostic tools". Iran J Med Sci. 39 (2 Suppl): 158–70. PMC 3993046. PMID 24753638.
- ↑ Stuhlmann-Laeisz C, Oschlies I, Klapper W (December 2014). "Detection of EBV in reactive and neoplastic lymphoproliferations in adults-when and how?". J Hematop. 7 (4): 165–170. doi:10.1007/s12308-014-0209-0. PMC 4243011. PMID 25478033.
- ↑ Chen B, Hentzelman JI, Walker RJ, Lai JP (2016). "Oncocytoma of the Submandibular Gland: Diagnosis and Treatment Based on Clinicopathology". Case Rep Otolaryngol. 2016: 8719030. doi:10.1155/2016/8719030. PMC 5045990. PMID 27722003.
- ↑ Kim KH, Sung MW, Kim JW, Koo JW (July 2000). "Pleomorphic adenoma of the trachea". Otolaryngol Head Neck Surg. 123 (1 Pt 1): 147–8. doi:10.1067/mhn.2000.102809. PMID 10889498.
- ↑ Pramod Krishna B (June 2013). "Pleomorphic Adenoma of Minor Salivary Gland in a 14 year Old Child". J Maxillofac Oral Surg. 12 (2): 228–31. doi:10.1007/s12663-010-0125-5. PMC 3681990. PMID 24431845.
- ↑ Kessler AT, Bhatt AA (2018). "Review of the Major and Minor Salivary Glands, Part 2: Neoplasms and Tumor-like Lesions". J Clin Imaging Sci. 8: 48. doi:10.4103/jcis.JCIS_46_18. PMC 6251244. PMID 30546932.
- ↑ Chenevert J, Barnes LE, Chiosea SI (February 2011). "Mucoepidermoid carcinoma: a five-decade journey". Virchows Arch. 458 (2): 133–40. doi:10.1007/s00428-011-1040-y. PMID 21243374.
- ↑ Jones AV, Craig GT, Speight PM, Franklin CD (April 2008). "The range and demographics of salivary gland tumours diagnosed in a UK population". Oral Oncol. 44 (4): 407–17. doi:10.1016/j.oraloncology.2007.05.010. PMID 17825603.
- ↑ Beltran D, Faquin WC, Gallagher G, August M (March 2006). "Selective immunohistochemical comparison of polymorphous low-grade adenocarcinoma and adenoid cystic carcinoma". J. Oral Maxillofac. Surg. 64 (3): 415–23. doi:10.1016/j.joms.2005.11.027. PMID 16487803.
- ↑ Mlika M, Kourda N, Zidi Y, Aloui R, Zneidi N, Rammeh S, Zermani R, Jilani SB (January 2012). "Salivary duct carcinoma of the parotid gland". J Oral Maxillofac Pathol. 16 (1): 134–6. doi:10.4103/0973-029X.92992. PMC 3303509. PMID 22434951.
- ↑ Schmitt NC, Kang H, Sharma A (November 2017). "Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy". Oral Oncol. 74: 40–48. doi:10.1016/j.oraloncology.2017.09.008. PMC 5685667. PMID 29103750.
- ↑ Simpson RH (July 2013). "Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification". Head Neck Pathol. 7 Suppl 1: S48–58. doi:10.1007/s12105-013-0456-x. PMC 3712088. PMID 23821208.
- ↑ Manvikar V, Ramulu S, Ravishanker ST, Chakravarthy C (May 2014). "Squamous cell carcinoma of submandibular salivary gland: A rare case report". J Oral Maxillofac Pathol. 18 (2): 299–302. doi:10.4103/0973-029X.140909. PMC 4196305. PMID 25328317.
- ↑ Ying YL, Johnson JT, Myers EN (July 2006). "Squamous cell carcinoma of the parotid gland". Head Neck. 28 (7): 626–32. doi:10.1002/hed.20360. PMID 16475198.
- ↑ Wei CH, Harari A (March 2012). "Parathyroid carcinoma: update and guidelines for management". Curr Treat Options Oncol. 13 (1): 11–23. doi:10.1007/s11864-011-0171-3. PMID 22327883.
- ↑ Sahasranam P, Tran MT, Mohamed H, Friedman TC (August 2007). "Multiglandular parathyroid carcinoma: a case report and brief review". South. Med. J. 100 (8): 841–4. doi:10.1097/SMJ.0b013e318073ca37. PMID 17713315.
- ↑ Holmes EC, Morton DL, Ketcham AS (April 1969). "Parathyroid carcinoma: a collective review". Ann. Surg. 169 (4): 631–40. PMC 1387475. PMID 4886854.
- ↑ Sajid MS, Hamilton G, Baker DM (August 2007). "A multicenter review of carotid body tumour management". Eur J Vasc Endovasc Surg. 34 (2): 127–30. doi:10.1016/j.ejvs.2007.01.015. PMID 17400487.
- ↑ Boedeker CC, Ridder GJ, Schipper J (2005). "Paragangliomas of the head and neck: diagnosis and treatment". Fam. Cancer. 4 (1): 55–9. doi:10.1007/s10689-004-2154-z. PMID 15883711.
- ↑ Pellitteri PK, Rinaldo A, Myssiorek D, Gary Jackson C, Bradley PJ, Devaney KO, Shaha AR, Netterville JL, Manni JJ, Ferlito A (July 2004). "Paragangliomas of the head and neck". Oral Oncol. 40 (6): 563–75. doi:10.1016/j.oraloncology.2003.09.004. PMID 15063383.
- ↑ Darouassi Y, Alaoui M, Mliha Touati M, Al Maghraoui O, En-Nouali A, Bouaity B, Ammar H (August 2017). "Carotid Body Tumors: A Case Series and Review of the Literature". Ann Vasc Surg. 43: 265–271. doi:10.1016/j.avsg.2017.03.167. PMID 28478173.
- ↑ Neumann HP, Pawlu C, Peczkowska M, Bausch B, McWhinney SR, Muresan M, Buchta M, Franke G, Klisch J, Bley TA, Hoegerle S, Boedeker CC, Opocher G, Schipper J, Januszewicz A, Eng C (August 2004). "Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations". JAMA. 292 (8): 943–51. doi:10.1001/jama.292.8.943. PMID 15328326.
- ↑ Erickson D, Kudva YC, Ebersold MJ, Thompson GB, Grant CS, van Heerden JA, Young WF (November 2001). "Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients". J. Clin. Endocrinol. Metab. 86 (11): 5210–6. doi:10.1210/jcem.86.11.8034. PMID 11701678.
- ↑ O'Riordain DS, Young WF, Grant CS, Carney JA, van Heerden JA (September 1996). "Clinical spectrum and outcome of functional extraadrenal paraganglioma". World J Surg. 20 (7): 916–21, discussion 922. PMID 8678971.
- ↑ Hilton DA, Hanemann CO (April 2014). "Schwannomas and their pathogenesis". Brain Pathol. 24 (3): 205–20. doi:10.1111/bpa.12125. PMID 24450866.
- ↑ Albert P, Patel J, Badawy K, Weissinger W, Brenner M, Bourhill I, Parnell J (2017). "Peripheral Nerve Schwannoma: A Review of Varying Clinical Presentations and Imaging Findings". J Foot Ankle Surg. 56 (3): 632–637. doi:10.1053/j.jfas.2016.12.003. PMID 28237565.
- ↑ Wong B, Bathala S, Grant D (January 2017). "Laryngeal schwannoma: a systematic review". Eur Arch Otorhinolaryngol. 274 (1): 25–34. doi:10.1007/s00405-016-4013-6. PMID 27020268. Vancouver style error: initials (help)
- ↑ Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT (December 1982). "Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute". Cancer. 50 (12): 2699–707. PMID 7139563.
- ↑ Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT (December 1982). "Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute". Cancer. 50 (12): 2699–707. PMID 7139563.
- ↑ Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S (August 2004). "B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review". Int. J. Cancer. 111 (1): 1–8. doi:10.1002/ijc.20205. PMID 15185336.
- ↑ Moormeier JA, Williams SF, Golomb HM (February 1990). "The staging of non-Hodgkin's lymphomas". Semin. Oncol. 17 (1): 43–50. PMID 2406917.
- ↑ Negri E, Little D, Boiocchi M, La Vecchia C, Franceschi S (August 2004). "B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review". Int. J. Cancer. 111 (1): 1–8. doi:10.1002/ijc.20205. PMID 15185336.
- ↑ Anderson T, Chabner BA, Young RC, Berard CW, Garvin AJ, Simon RM, DeVita VT (December 1982). "Malignant lymphoma. 1. The histology and staging of 473 patients at the National Cancer Institute". Cancer. 50 (12): 2699–707. PMID 7139563.
- ↑ Evans HL (January 2007). "Atypical lipomatous tumor, its variants, and its combined forms: a study of 61 cases, with a minimum follow-up of 10 years". Am. J. Surg. Pathol. 31 (1): 1–14. doi:10.1097/01.pas.0000213406.95440.7a. PMID 17197914.
- ↑ Conyers R, Young S, Thomas DM (2011). "Liposarcoma: molecular genetics and therapeutics". Sarcoma. 2011: 483154. doi:10.1155/2011/483154. PMC 3021868. PMID 21253554.
- ↑ Alaggio R, Coffin CM, Weiss SW, Bridge JA, Issakov J, Oliveira AM, Folpe AL (May 2009). "Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age". Am. J. Surg. Pathol. 33 (5): 645–58. doi:10.1097/PAS.0b013e3181963c9c. PMID 19194281.
- ↑ Serpell JW, Chen RY (July 2007). "Review of large deep lipomatous tumours". ANZ J Surg. 77 (7): 524–9. doi:10.1111/j.1445-2197.2007.04042.x. PMID 17610686.
- ↑ de Bree E, Karatzanis A, Hunt JL, Strojan P, Rinaldo A, Takes RP, Ferlito A, de Bree R (May 2015). "Lipomatous tumours of the head and neck: a spectrum of biological behaviour". Eur Arch Otorhinolaryngol. 272 (5): 1061–77. doi:10.1007/s00405-014-3065-8. PMID 24800932.
- ↑ Rydholm A, Berg NO (December 1983). "Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma". Acta Orthop Scand. 54 (6): 929–34. PMID 6670522.
- ↑ Myhre-Jensen O (June 1981). "A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas". Acta Orthop Scand. 52 (3): 287–93. PMID 7282321.
- ↑ Urquhart AC, Johnson JT, Myers EN, Schechter GL (April 1994). "Glomus vagale: paraganglioma of the vagus nerve". Laryngoscope. 104 (4): 440–5. doi:10.1288/00005537-199404000-00008. PMID 8164483.
- ↑ Valavanis A, Schubiger O, Oguz M (1983). "High-resolution CT investigation of nonchromaffin paragangliomas of the temporal bone". AJNR Am J Neuroradiol. 4 (3): 516–9. PMID 6308990.
- ↑ Urquhart AC, Johnson JT, Myers EN, Schechter GL (April 1994). "Glomus vagale: paraganglioma of the vagus nerve". Laryngoscope. 104 (4): 440–5. doi:10.1288/00005537-199404000-00008. PMID 8164483.
- ↑ Stein PP, Black HR (January 1991). "A simplified diagnostic approach to pheochromocytoma. A review of the literature and report of one institution's experience". Medicine (Baltimore). 70 (1): 46–66. PMID 1988766.
- ↑ Sajid MS, Hamilton G, Baker DM (August 2007). "A multicenter review of carotid body tumour management". Eur J Vasc Endovasc Surg. 34 (2): 127–30. doi:10.1016/j.ejvs.2007.01.015. PMID 17400487.
- ↑ Boedeker CC, Ridder GJ, Schipper J (2005). "Paragangliomas of the head and neck: diagnosis and treatment". Fam. Cancer. 4 (1): 55–9. doi:10.1007/s10689-004-2154-z. PMID 15883711.
- ↑ Gluckman JL, Robbins KT, Fried MP (1990). "Cervical metastatic squamous carcinoma of unknown or occult primary source". Head Neck. 12 (5): 440–3. PMID 2211107.
- ↑ Waltonen JD, Ozer E, Hall NC, Schuller DE, Agrawal A (October 2009). "Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup". Arch. Otolaryngol. Head Neck Surg. 135 (10): 1024–9. doi:10.1001/archoto.2009.145. PMID 19841343.
- ↑ Feldman PS, Kaplan MJ, Johns ME, Cantrell RW (November 1983). "Fine-needle aspiration in squamous cell carcinoma of the head and neck". Arch Otolaryngol. 109 (11): 735–42. PMID 6639441.
- ↑ Grénman R, Koivunen P, Minn H (2015). "[Laryngeal cancer in Finland]". Duodecim (in Finnish). 131 (4): 331–7. PMID 26237923.
- ↑ Guneyli S, Cinar C, Bozkaya H, Korkmaz M, Oran I (September 2016). "Endovascular management of congenital arteriovenous fistulae in the neck". Diagn Interv Imaging. 97 (9): 871–5. doi:10.1016/j.diii.2015.08.006. PMID 26972281.
- ↑ Gobin YP, Garcia de la Fuente JA, Herbreteau D, Houdart E, Merland JJ (November 1993). "Endovascular treatment of external carotid-jugular fistulae in the parotid region". Neurosurgery. 33 (5): 812–6. PMID 8264877.
- ↑ Madjar S, Weissberg D (July 1995). "Retrosternal goiter". Chest. 108 (1): 78–82. PMID 7606997.
- ↑ Hedayati N, McHenry CR (March 2002). "The clinical presentation and operative management of nodular and diffuse substernal thyroid disease". Am Surg. 68 (3): 245–51, discussion 251–2. PMID 11893102.
- ↑ Hughes K, Eastman C (August 2012). "Goitre - causes, investigation and management". Aust Fam Physician. 41 (8): 572–6. PMID 23145396.
- ↑ Hermus AR, Huysmans DA (August 2000). "[Diagnosis and therapy of patients with euthyroid goiter]". Ned Tijdschr Geneeskd (in Dutch; Flemish). 144 (34): 1623–7. PMID 10972051.
Diseases | Clinical manifestations | Para-clinical findings | Pap Smear | Histopathology | Gold standard | Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | ||||||||||||||
Menorrhagia | Post Menstrual
Bleeding |
Pelvic Pain | Other
symptoms |
Pelvic examination | Abdominal examination | Hb | B-HCG | CEA-19 | Ultrasound | MRI | |||||
Endometrial cancer | + | + | ↓ | + | |||||||||||
Uterine | +/- | + | ↓ | + | |||||||||||
Uterine | +/- | +/- | ↓
or N |
||||||||||||
Uterine leiomyoma | +/- | +/- | ↓
or N |
||||||||||||
Malignant mixed
Mullerian tumour (MMMT) of the uterus |
+/- | +/- | ↓ | ||||||||||||
Cervical cancer
with uterine invasion |
+ | + | ↓ | ||||||||||||
Metastasis to the uterus from a
non-gynaecologcial malignancy |
+ | + | ↓ | ||||||||||||
Endometrial | + | + | ↓ | +
or N |
|||||||||||
Endometrial | + | + | ↓ | + | |||||||||||
Uterine | - | - | ↓ | + | |||||||||||
Hematometra | - | - | ↓ | + | |||||||||||
Gestational | |||||||||||||||
Incomplete | |||||||||||||||
Fetus | No
Menstrual cycle |
+/- | - | ||||||||||||
Diseases | Clinical manifestations | Para-clinical findings | Gold standard | Additional findings | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | Physical examination | ||||||||||||||
Lab Findings | Imaging | Histopathology | |||||||||||||
Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | ||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Differential Diagnosis 1 | |||||||||||||||
Differential Diagnosis 2 | |||||||||||||||
Differential Diagnosis 3 | |||||||||||||||
Diseases | Symptom 1 | Symptom 2 | Symptom 3 | Physical exam 1 | Physical exam 2 | Physical exam 3 | Lab 1 | Lab 2 | Lab 3 | Imaging 1 | Imaging 2 | Imaging 3 | Histopathology | Gold standard | Additional findings |
Differential Diagnosis 4 | |||||||||||||||
Differential Diagnosis 5 | |||||||||||||||
Differential Diagnosis 6 |
Table for Differential Diagnosis of Small Intestine Cancer
ABBREVIATIONS:
N/A: Not available, NL: Normal,